Adicet Bio ACET Stock
$6.50
-2.108432%
Add to favorites
SECTOR
INDUSTRY
COUNTRY
Exchange
Market Cap
$60.85M
LOW - HIGH [24H]
$6.50
-
$6.82
VOLUME [24H]
$164.98K
P/E Ratio
0
Earnings per share
-$10.42
ISIN
US0070021086
Adicet Bio Price Chart
Adicet Bio ACET Financial and Trading Overview
| Adicet Bio stock price | 6.5 USD |
| Previous Close | 6.64 USD |
| Open | 6.7 USD |
| Bid | 5.04 USD x 200 |
| Ask | 8.58 USD x 200 |
| Day's Range | 6.5 - 6.82 USD |
| 52 Week Range | 6.01 - 17.44 USD |
| Volume | 164.66K USD |
| Avg. Volume | 162.58K USD |
| Market Cap | 60.85M USD |
| Beta (5Y Monthly) | 1.587 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -10.42 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 34.83 USD |
ACET Valuation Measures
| Enterprise Value | -35367900 USD |
| Trailing P/E | N/A |
| Forward P/E | -1.6089109 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.58238506 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.36 |
Trading Information
Adicet Bio Stock Price History
| Beta (5Y Monthly) | 1.587 |
| 52-Week Change | -58.50% |
| S&P500 52-Week Change | 14.15% |
| 52 Week High | 17.44 USD |
| 52 Week Low | 6.01 USD |
| 50-Day Moving Average | 8.71 USD |
| 200-Day Moving Average | 8.02 USD |
ACET Share Statistics
| Avg. Volume (3 month) | 162.58K USD |
| Avg. Daily Volume (10-Days) | 468.64K USD |
| Shares Outstanding | 9.36M |
| Float | 7.43M |
| Short Ratio | 2.28 |
| % Held by Insiders | 1.07% |
| % Held by Institutions | 64.70% |
| Shares Short | 271.99K |
| Short % of Float | 2.91% |
| Short % of Shares Outstanding | 2.91% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:16 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -41.66% |
| Return on Equity (ttm) | -78.082% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -98121000 USD |
| Net Income Avi to Common (ttm) | -98974000 USD |
| Diluted EPS (ttm) | -10.22 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 118.19M USD |
| Total Cash Per Share (mrq) | 10.98 USD |
| Total Debt (mrq) | 12.85M USD |
| Total Debt/Equity (mrq) | 10.7 USD |
| Current Ratio (mrq) | 6.709 |
| Book Value Per Share (mrq) | 11.161 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -84529000 USD |
| Levered Free Cash Flow (ttm) | -47516124 USD |
Profile of Adicet Bio
| Country | United States |
| State | MA |
| City | Boston |
| Address | 131 Dartmouth Street |
| ZIP | 02116 |
| Phone | 650 503 9095 |
| Website | https://www.adicetbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 102 |
Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. The company's lead product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR that targets CD20 for the potential treatment of autoimmune diseases. It also develops ADI-212, a gene-edited and armored clinical candidate that targets prostate-specific membrane antigen. The company was founded in 2014 and is based in Boston, Massachusetts.
Q&A For Adicet Bio Stock
What is a current ACET stock price?
Adicet Bio ACET stock price today per share is 6.5 USD.
How to purchase Adicet Bio stock?
You can buy ACET shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Adicet Bio?
The stock symbol or ticker of Adicet Bio is ACET.
Which industry does the Adicet Bio company belong to?
The Adicet Bio industry is Biotechnology.
How many shares does Adicet Bio have in circulation?
The max supply of Adicet Bio shares is 9.36M.
What is Adicet Bio Price to Earnings Ratio (PE Ratio)?
Adicet Bio PE Ratio is now.
What was Adicet Bio earnings per share over the trailing 12 months (TTM)?
Adicet Bio EPS is -10.42 USD over the trailing 12 months.
Which sector does the Adicet Bio company belong to?
The Adicet Bio sector is Healthcare.
Adicet Bio ACET included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
27190.86 USD — |
+1.19
|
6.86B USD — | 27112.24 USD — | 27353.68 USD — | — - | 6.86B USD — |
|
US Tech Composite Total Return
XCMP
US
|
33588.44 USD — |
+1.19
|
— — | 33491.32 USD — | 33789.56 USD — | — - | — — |
|
Stlmt ID US Tech Biotechnology
NBX
US
|
4000.62 USD — |
-1.26
|
— — | 3927.42 USD — | 4148.65 USD — | — - | — — |
|
US Tech Global Market Composite
NQGM
US
|
2166.96 USD — |
+0.27
|
— — | 2163.08 USD — | 2188.89 USD — | — - | — — |
|
US Tech Biotechnology
NBI
US
|
6947.64 USD — |
-0.26
|
— — | 6917.55 USD — | 6998.5 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1302.61 USD — |
-0.29
|
— — | 1298.55 USD — | 1311.62 USD — | — - | — — |
- {{ link.label }} {{link}}
